What is hemoptysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Hemoptysis?

Hemoptysis is the expectoration of blood from the lung alveoli or airways of the lower respiratory tract, originating from the tracheobronchial tree rather than from nasopharyngeal or gastrointestinal sources. 1

Clinical Definition and Differentiation

  • Hemoptysis specifically refers to blood or blood-stained mucus coughed up from the lower respiratory tract, typically originating from bronchial arteries. 2, 3
  • This must be distinguished from pseudohemoptysis (blood from nasopharyngeal sources) and hematemesis (blood from gastrointestinal sources). 2
  • The blood in true hemoptysis comes from the lung alveoli or conducting airways below the larynx. 1

Classification by Severity

The severity classification is critical because morbidity and mortality correlate more closely with the rate of bleeding than the absolute volume expectorated. 4

Mild Hemoptysis

  • Less than 30 mL of blood in 24 hours 4
  • Comprises more than 90% of cases and has a good prognosis 2
  • Generally does not require bronchoscopic therapy 1

Moderate to Severe Hemoptysis

  • 30-300 mL of blood in 24 hours 4

Massive Hemoptysis

  • Most commonly defined as greater than 200-400 mL of blood in 24 hours, though some use a threshold as low as 100 mL when there is risk of asphyxiation. 4
  • Mortality rate ranges from 59% to 100% in patients with lung cancer 1
  • Fatal massive hemoptysis results more commonly from asphyxiation rather than exsanguination, as blood clot formation obstructing the airways is the primary mechanism of respiratory failure. 1
  • Requires urgent bronchoscopy for airway protection regardless of exact volume 4

Common Causes

The etiology varies significantly by geographic location and healthcare setting:

In Outpatient Primary Care Settings

  • Acute respiratory tract infections (most common) 1
  • Chronic obstructive pulmonary disease 1
  • Malignancy 1
  • Bronchiectasis 1

In Tertiary Referral Centers (North America/Europe)

  • Bronchiectasis 1
  • Respiratory infections 1
  • Lung carcinomas 1

In Developing Countries

  • Tuberculosis and its sequelae remain the most prevalent cause 1

Additional Important Causes

  • Sarcoidosis 1
  • Autoimmune diseases causing capillaritis or cavitation 1
  • Coagulopathies 1
  • Vascular causes including pulmonary arteriovenous malformations, pulmonary pseudoaneurysms, and pulmonary artery aneurysms 1
  • Pulmonary embolus is an uncommon cause despite common clinical concern 1

Cryptogenic Hemoptysis

  • Accounts for approximately 20% of patients who undergo extensive investigation with both CT and bronchoscopy without identifying a cause 1
  • This is a diagnosis of exclusion after complete workup 5

Clinical Presentation in Malignancy

  • Hemoptysis is the presenting symptom in 7% to 10% of patients with lung cancer 1
  • More likely with cancers involving the airways (squamous cell carcinoma, small cell carcinoma, carcinoid tumors) than peripheral parenchymal lesions like adenocarcinoma 1
  • Cough is present in greater than 65% of lung cancer patients at diagnosis, with productive cough in greater than 25% 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hemoptysis: Evaluation and Management.

American family physician, 2022

Research

Diagnosis and Treatment of Hemoptysis.

Archivos de bronconeumologia, 2016

Guideline

Classification and Management of Hemoptysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Differential Diagnosis of Hemoptysis in Young Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.